PAMS
KDNY

Pictet Asset Management (Switzerland)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		$877K Sell
22,829
-1,151,927
-98% -$44.3M ﹤0.01% 1015
2023
Q1 		$27.2M Buy
1,174,756
+8,592
+0.7% +$199K 0.03% 388
2022
Q4 		$30.6M Buy
1,166,164
+484,052
+71% +$12.7M 0.04% 354
2022
Q3 		$13.4M Buy
+682,112
New +$13.4M 0.02% 512